Immix Biopharma, Inc. (IMMX)
9.42
+0.13
(+1.40%)
USD |
NASDAQ |
Oct 09, 09:42
Immix Biopharma Market Cap : 673.87M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 664.57M |
| October 07, 2026 | 678.87M |
| October 06, 2026 | 689.60M |
| October 05, 2026 | 724.66M |
| October 02, 2026 | 692.47M |
| October 01, 2026 | 731.81M |
| September 30, 2026 | 744.33M |
| September 29, 2026 | 753.99M |
| September 28, 2026 | 820.51M |
| September 25, 2026 | 784.75M |
| September 24, 2026 | 836.97M |
| September 23, 2026 | 852.71M |
| September 22, 2026 | 917.80M |
| September 21, 2026 | 892.05M |
| September 18, 2026 | 894.20M |
| September 17, 2026 | 909.93M |
| September 16, 2026 | 852.71M |
| September 15, 2026 | 868.44M |
| September 14, 2026 | 873.45M |
| September 11, 2026 | 868.44M |
| September 10, 2026 | 908.50M |
| September 09, 2026 | 880.60M |
| September 08, 2026 | 947.85M |
| September 04, 2026 | 995.06M |
| September 03, 2026 | 989.34M |
| Date | Value |
|---|---|
| September 02, 2026 | 998.64M |
| September 01, 2026 | 1.002B |
| August 31, 2026 | 1.004B |
| August 28, 2026 | 997.21M |
| August 27, 2026 | 1.024B |
| August 26, 2026 | 1.007B |
| August 25, 2026 | 1.035B |
| August 24, 2026 | 973.60M |
| August 21, 2026 | 977.18M |
| August 20, 2026 | 941.41M |
| August 19, 2026 | 943.56M |
| August 18, 2026 | 844.84M |
| August 17, 2026 | 811.21M |
| August 14, 2026 | 784.75M |
| August 13, 2026 | 781.17M |
| August 12, 2026 | 813.36M |
| August 11, 2026 | 821.95M |
| August 10, 2026 | 724.66M |
| August 07, 2026 | 695.33M |
| August 06, 2026 | 719.65M |
| August 05, 2026 | 682.45M |
| August 04, 2026 | 494.60M |
| August 03, 2026 | 446.36M |
| July 31, 2026 | 441.06M |
| July 30, 2026 | 453.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Atossa Therapeutics, Inc. | 24.95M |
| ACADIA Pharmaceuticals, Inc. | 3.408B |
| Alnylam Pharmaceuticals, Inc. | 30.68B |
| Savara, Inc. | 1.009B |
| Vericel Corp. | 2.078B |
Market Cap Related Metrics
| PEG Ratio | -0.9550 |
| Price to Book Value | 2.944 |
| Price | 9.42 |
| Earnings Yield | -9.34% |
| PEGY Ratio | -0.9550 |